# Eli Lilly to allow more patients to apply for special access to unapproved obesity drug

> **Open Intelligence Dossier** · First detected: 2026-08-04 14:07 UTC · Category: Business

## Executive Summary
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Eli Lilly to allow more patients to apply for special access to unapproved obesity drug" is generating significant coverage in the Business category, with 11 articles from 10 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Houston Chronicle, MDLinx, STAT and RAPS. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Houston Chronicle | Eli Lilly will offer experimental obesity drug early to some patients. Who qualifies? | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxQZEhwZHREZENuTDVBV2NucGJldkF1akVPWlNDN0I1ZzhUZEFnSm1rRkFkQTRfenhRbng3bWgxaEgzdzU1Tm5WQ3pMZS1aS2pTVDhJZ0xNQzhkUUpOb25oTTJRTGZXMWw5aHFoVkhuMUs0SVFjQWpITnVmSi1VOV80QlAtdnRXVEJjNTFWSUd5cHlXTVRQWXh5V1RGeWN2V09EZlNQalNB?oc=5) |
| MDLinx | Retatrutide access expands, putting physicians on the front line of ‘next-gen’ GLP-1 demand | [Source Link](https://news.google.com/rss/articles/CBMi2gFBVV95cUxPaVEydjM4OGxWSmMzQUQtRGJ4U05GYmpKeGlDejVuazVicWxLb1NiYkk1TEFOTFFxZjFzcGt2dzhmZ1FXWmRuTl9Kbk81YjRxWmZSb1N5TDVOYTEwUW1ESGlOYWRYTzBhdEkzX2N4dnFLZHBDZEJOaFh1SHZ0dGotcGQ1cURYMGk5T1NlYl9Lc19Ba3hsdl9TWDUtRDFrTmRtVDBMWFQyUGdMOUFNQ0Zzem45MVg1T2hJX2tFSFNqTjF2Sms5dWtEQ2NWcVdONXFwaC1LMGFlSFNUZw?oc=5) |
| STAT | Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxPUjdfcmtFb3pFalBZVVY1ZnlkSkE2RklYMXBPVVdrSy04ZDUzM09tSFo3NXB5VHhFQlEySENBemhLcmI1UWt2V0R1SllValNpY056TXFVQkdxeTVBNWtNSHFNRFpYYlItUVpZQmtPSTZSQ25qdEhTVDBnNVlYVkloT25mSk5fZ09FTnZQVHpqRTBNcHI2WDRTSWhkWVlaRzdtd1VjdnN4YWhvUnhC?oc=5) |
| RAPS | Recon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca | [Source Link](https://news.google.com/rss/articles/CBMi8AFBVV95cUxOSVExR0pEVTJ6OWR3eHd0WnB3ZlZTa052NHV6aHktLU5taXh5dU4wSFlfcFhHOG9Ncl9VMjExRFlzRTJxTW5jZVJUZ2M2akEyMDJIcWdCLXUxZmt1RklLcFg4OEUzMl9SdzJSMWh2OUhKMEVWWjdxdGJMRVZQQXNscUhpUmxTTVI2Y052eHUtcVdlV2VSZ25vazUwV29Cbm55VkhDYkxDdHptOGdYb0MyS0YyVE93NmJtMXgwSlRJNjBkYm5ycDNxVFQ4dWRqYXJNZmN1dTVpNlQyQ0VmU3ZPUnlmdFpBdmVqM3h4WjkwaDU?oc=5) |
| qz.com | Eli Lilly expanding early access to retatrutide weight loss drug | [Source Link](https://news.google.com/rss/articles/CBMid0FVX3lxTE1GVzBoMzVDc2Q0bjM4Um96aW5PQk1QTmhnQXNJbmw3SkNwWUVjcnJhcTdUV1ltejBEQTJETkg0TDU4NGZ3aWdfMlJfOHJZRWFFSkVCa05CZ3d5SXlyeWh5dDY2MnpBTlpnb2ZGVWthV3ZQQWFvcGtJ?oc=5) |
| statnews.com | Three biotechs with three news updates | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxNVndmeVFhbVpWTzczRWx4WGF3S2YzeVdSTWcwa2lUVXdkeFFQSFlzS21tRTZEQVR1R3c2MnBucmdJYXFhV0phcU1HaWo1RjFrcXRlcmhjLXByWFlCV2xxQnRRLTUyZXBGQmFqSWhvNm9HUnNMeVN4aVNrNWdEWlNla1BwUUNESVZKa28wOTduNE5jLWplQmxQN1Z6emFOSk9DZG5QZjFGNVNiUHNw?oc=5) |
| Marie Claire | This Next-Gen GLP-1 Is Blowing Up the Black Market Economy | [Source Link](https://news.google.com/rss/articles/CBMibEFVX3lxTE1hdjhPNWFzYU1FQ1Fwb3h5TzZCNHVrUUE1TFI4bE4yWnJEeVNGdXA5c0RjR183SDBPVjBvRHJwcDI1dk85MnJyeXJySF9RdTJORDctWm5ydV93TGZHQjR4Nzh5SUZzSUpvb3FuSA?oc=5) |
| FC Bayern | Retta Weight Loss: The Evidence, Benefits, and Realistic Expectations - View QMQEr6GEs | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxQMzJsVEk0QnlFenBiTi1MRVljX2RhaUFoTVNrcG5Yc0NWUFJxeVNHRkZtdmlabjB1NHNLaHZXdmJ5WHhZdkNUTncyMzhTcmN0dE1hNjRQbnZZQXpJMXJMUmx6TGVpeFdvMGthb1VyMl9aNFhjaVRNeFI1Q1pCbmc1SXZRZlktZ0tPb3A5WXlXV3BQeElGamluSlVmMHQyYUtMWjFQOHVzTE0zS2ZjUVgydURTS2h4dmRCUGxmTWlJcHdWMUV0SFZrb0prel9KYlgtVlFMODF1eGljUU5qakFUdQ?oc=5) |
| FirstWord Pharma | Spotlight On: Good news and bad news for Lilly's triple agonist | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE90REhGZHFwR200aThXbWF5ek0yVGhtV2kwSlpMdVBfa1hnSmhxdHJvV3VrVG05ekNhZXFMRGFwd2w1ck12ZjYzU1kzWm9BT1NKWU9F?oc=5) |
| reuters.com | Eli Lilly to offer early access to next-gen obesity drug to some patients | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSUF6THY1UW04aGlCR241STFzUE94MXlyMjZFSVNWaG9aYkRPVFVvdW5FRVZ3NHd3RXQzSjkybFhCWEhZZVpNTExxSDlwNDNRWW95SG0xcGVUVVozU09SMHR3RUR5b3Q2SFNYaTZvbzBWbV9fNTA4WjVOTGk1cUdhYkN2bl9rR19VcmpFV256VktIb243aHpZQ1RxNVR5ZldFNkpKUk9NNVFjb2Nmd1NxcFBDVzFnMURv?oc=5) |
| STAT | Eli Lilly to allow more patients to apply for special access to unapproved obesity drug | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxPZlc2WHdHQWtOSElxbmxZa1ZTQ2wxVTFmZ1dlN00teWRicmdqZTJVTjZUSjNKcEltUHZITTViR3U5NFk3cXRmWmRGWGpOSERRWWFta3NqNjlFRF9qRjVmNGNXTEVUazNURjZkRUZFQjl1QkxuNVM4aWlwNGtYVmY0OG5Sc042Q3FrRGVLVTJTaEp1R0dLVnA2My1YUG84MmJCdEdWWEMzNGZpQ2ZPR205WW15b2U?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-04/eli-lilly-to-allow-more-patients-to-apply-for-special-access-to-unapproved*